SA

Sayed Ansar

Active Director Director DIN 10689982
DIN 10689982 First appointment Jul 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sayed Ansar

Data last updated:

Sayed Ansar is a Director at Dr Winz Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10689982
Primary Designation Director
Industry Paper
First Appointment 04 Jul 2024
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jul 20242023Active

Directorship timeline

Open interactive timeline →
Dr Winz Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sayed Ansar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sayed Ansar

Sayed Ansar currently holds 1 directorship: Dr Winz Pharmaceuticals Private Limited (Director, since 04 Jul 2024).

Sayed Ansar was first appointed on 04 Jul 2024 as Director at Dr Winz Pharmaceuticals Private Limited.

The current boards of Sayed Ansar's companies include Mahanthi Salamkayala (Dr Winz Pharmaceuticals Private Limited), Adithya Maddali (Dr Winz Pharmaceuticals Private Limited), Bheemisetty Sarath Chakravarthi (Dr Winz Pharmaceuticals Private Limited), Budigi Anjaiah (Dr Winz Pharmaceuticals Private Limited), Dawood Basha Syed (Dr Winz Pharmaceuticals Private Limited), Paparao Bhimisetty (Dr Winz Pharmaceuticals Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available